ecancermedicalscience

Case Report

High dose interstitial brachytherapy for treatment of carcinoma of the lip as an alternative to surgery: a case report

30 Sep 2021
Percy Torres-Quispe, Lissett Jeanette Fernández-Rodríguez, Yaowen Zhang, Angeles Rovirosa-Casino

Lip cancer (LC) is the most common cancer of the oral cavity and is the second most common in the head and neck. Brachytherapy (BT) is a good treatment option for this type of cancer because it administers high doses of radiation to the target. BT has similar cure and survival rates as surgery for the same type of cancer, but it often produces more favourable aesthetic results, especially when the tumour is treated in its early stages. We present a case of a patient diagnosed with stage II lower LC who refused surgical treatment. Instead, high-dose-rate interstitial BT was performed with 192Ir. A 2-year post-treatment follow-up indicated there were neither serious complications nor recurrence of cancer during that period.

Related Articles

Sarthak Tandon, Manoj Gupta, Parveen Ahlawat, Madhur Verma, Apoorva Nayak, Akash Bellige, Kundan S Chufal, Jaskaran S Sethi, Anjali Pahuja, Shreya Rai, Abhishek Singh, Vikas Arora, Vishal Yadav, David K Simson, Irfan Ahmad, Sandeep Singh, Dipesh Vashisht, Azhar Ansari, Rashmi Bansal, Abhishek Bhadri, Harsh Vyas, Manindra Mishra, Rajat Saha, Mudit Agarwal, Partha S Chowdhary, Ajay K Dewan, Munish Gairola
Samapika Bhaumik, Prarabdh Singh, Narapareddy Venkata Dinesh Reddy, Shreya Jain, Sambit S Nanda, Paramita Paul, Ashutosh Mukherji, Satyajit Pradhan